MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-KR-06-0002768
Shreegen Pharma Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹9.2 Cr
▼ 32% YoY
Net profit · FY 2023
₹1.32 Lakh
Net margin 0.1%
EBITDA · FY 2023
₹75.93 Lakh
EBITDA margin 8.3%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹25 Cr
Issued & subscribed
Open charges
₹11.69 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Employees · EPFO
26
Provident fund records
About Shreegen Pharma Limited
Data last updated:
Shreegen Pharma Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 October 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2012PLC083695. Its GSTIN is 29AASCS2680K1ZJ (Karnataka). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹25 Cr. It is led by directors including Rama Mangeswar Reddy Bobbiti (Managing Director) and Kanaka Nallamilli Sundara Reddy.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹9.2 Cr, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹1.32 Lakh (net margin 0.1%) and EBITDA of ₹75.93 Lakh (EBITDA margin 8.3%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years and 16% over five years.
The company has about 26 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹11.69 Cr on record. Court records list 16 cases involving the company, including 3 filed by the company and 13 filed against it; 8 cases are pending. The company has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹13.15 Cr; the latest was in May 2022. Its 5 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Horster Biotek Private Limited with revenue of ₹9.25 Cr.
Shreegen Pharma Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-06-0002768). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shreegen.com.
Company details
CIN U24233TG2012PLC083695
Registration Number 083695
Incorporation Date 18 October 2012
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-06-0002768
CIN history
Shreegen Pharma has one previous CIN (Corporate Identification Number): U24233AP2012PLC083695. The current CIN is U24233TG2012PLC083695, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2012PLC083695 | Current |
| U24233AP2012PLC083695 | Previous |
Key People
Rama Mangeswar Reddy Bobbiti Managing Director Kanaka Nallamilli Sundara Reddy Director Chandra Balireddy Kotthapalli Additional Director Recognitions & Rankings of Shreegen Pharma
Contact details
Shreegen Pharma Limited's registered office is in Hyderabad, Telangana. Its website is shreegen.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressHno. 7 – 1 – 638 To 643 Flat 305 Bhanu Enclave, Beside Esi Hospital Sundernagar Erragadda, Hyderabad, Telangana, India – 500038
- IndustryPharma, API Manufacturers
To see the full contact details of Shreegen Pharma Limited, buy the company report.
Comprehensive company report
Shreegen Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Shreegen Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shreegen Pharma Limited, buy the company report.
Financials of Shreegen Pharma Limited
FY 2023 filings availableShreegen Pharma Limited reported revenue of ₹9.2 Cr (down 32% YoY) for FY 2023.
Revenue · FY 2023
₹9.2 Cr ▼ 32%
Net profit · FY 2023
₹1.32 Lakh margin 0.1%
EBITDA · FY 2023
₹75.93 Lakh margin 8.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 32%
3 years · compounded
▼ 33%
5 years · compounded
▼ 16%
EBITDA CAGR growth
1 year
▲ 145%
3 years · compounded
▼ 36%
5 years · compounded
▲ 17%
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 32% fall in the latest year. EBITDA rose 145% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹75.93 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shreegen Pharma Limited, buy the company report.
Board of directors of Shreegen Pharma Limited
Shreegen Pharma has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rama Mangeswar Reddy Bobbiti | Managing Director | 18 Oct 2012 | 14 Years 0 Months | Current |
| Kanaka Nallamilli Sundara Reddy Also directs: Symbiosis Feeds India Private Limited | Director | 30 Sep 2016 | 10 Years 1 Months | Current |
| Chandra Balireddy Kotthapalli Also directs: Aqzen Impex Private Limited | Additional Director | 14 May 2025 | 1 Years 5 Months | Current |
| Srinivasa Reddy Daka Also directs: SNR Infratech Private Limited | Director | 18 Oct 2012 | 14 Years 0 Months | Current |
| Rajeev Dinesh Srivastava Also directs: Trounce Life Sciences Private Limited | Additional Director | 14 May 2025 | 1 Years 5 Months | Current |
| Sishtla Ramakrishnan Also directs: Avidia Pharma Labs LLP, Aalto Biotech Private Limited, Srivar Pharma Private Limited and 2 more | Director | 01 Aug 2025 | 1 Years 3 Months | Current |
Peer comparison
Shreegen Pharma Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Horster Biotek Private Limited | ₹9.25 Cr (FY 2025) | 16.0% | Indore, Madhya Pradesh, India | |||
| Omkrown Pharam-Chem Private Limited | ₹9.22 Cr (FY 2025) | 6.0% | Nagar, Shahapur, Belgaum, Karnataka, India | |||
| Shreegen Pharma Limitedthis company | ₹9.2 Cr (FY 2023) | ₹1.32 Lakh | 0.1% | -32.0% | Hyderabad, Telangana, India | |
| Proventus Life Sciences Private Limited | ₹9.17 Cr (FY 2024) | -47.0% | Chennai, Tamil Nadu, India | |||
| Thexa Pharma Private Limited | ₹9.03 Cr (FY 2018) | -84.0% | Madgul, Telangana, India | |||
| Xenocor Pharmalab Private Limited | ₹8.98 Cr (FY 2024) | 75.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Shreegen Pharma Limited, buy the company report.
Auditor
Shreegen Pharma Limited is audited by LAKHOTIA & REDDY for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| LAKHOTIA & REDDY | FY 2021 | 009331S |
Shareholding
The shareholding of Shreegen Pharma Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shreegen Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹11.69 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Apr 2015 | 10569557 | State Bank of India | ₹11.69 Cr | Open |
To see the full charge records of Shreegen Pharma Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Shreegen Pharma Limited has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹13.15 Cr; the latest was in May 2022.
Total deals
9
Secondary share transfers
6
Funding rounds
2
Rights issue
1
Disclosed funding
₹13.15 Cr
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2022 | Funding round | ₹3.2 Cr | Investors: an individual |
| Sep 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
To see the full deal history of Shreegen Pharma Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Shreegen Pharma Limited has 16 court cases on record: 3 filed by Shreegen Pharma, 13 filed against it. 8 cases are pending and 8 are disposed.
Total cases
16
Filed by the company
3
Filed against the company
13
Pending
8
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 9 | 6 | 3 |
| District courts | 7 | 7 | 5 |
Cases on record (5 of 16)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by Hrishabh Chemicals Private Limited | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Lasa Supergenerics Limited | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Lasa Supergenerics Limited | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed by the company against Lasa Supergenerics Limited and Ors | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed against the company by Paarichem Resources LLP Through Sachin Vijay Rao | Disposed |
To see the full case history of Shreegen Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shreegen Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shreegen Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AASCS2680K1ZJ | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shreegen Pharma Limited, buy the company report.
Recent activity
Shreegen Pharma Limited has 11 board changes on record since 2012: 7 appointments and 4 cessations. The latest: Sishtla Ramakrishnan was appointed as Director on 01 Aug 2025.
Appointed
Sishtla Ramakrishnan was appointed as Director.
Appointed
Chandra Balireddy Kotthapalli was appointed as Additional Director.
Appointed
Rajeev Dinesh Srivastava was appointed as Additional Director.
AGM
Shreegen Pharma Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Shreegen Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Charges
A charge with State Bank Of India of Rs. 11.69 Cr registered on 13 Apr 2015 with Charge ID 10569557 was modified on 29 Sep 2021.
Ceased
Vikas Singhal ceased to be Director.
Ceased
Ramakrishnan Sishtla ceased to be Additional Director.
Ceased
Rama Mangeswar Reddy Bobbiti ceased to be Director.
Appointed
Kanaka Nallamilli Sundara Reddy was appointed as Director.
Appointed
Venkata Suryanarayana Reddy Chilukuri was appointed as CFO.
Charges
A charge with State Bank Of India amounted to Rs. 11.69 Cr with Charge ID 10569557 was registered on 13 Apr 2015.
4 earlier events are in the company report.
Frequently asked questions
Shreegen Pharma is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 18 October 2012 (14+ years old) and is registered under CIN U24233TG2012PLC083695.
Shreegen Pharma has 6 current directors:
- Rama Mangeswar Reddy Bobbiti - Managing Director
- Kanaka Nallamilli Sundara Reddy - Director
- Chandra Balireddy Kotthapalli - Additional Director
- Srinivasa Reddy Daka - Director
- Rajeev Dinesh Srivastava - Additional Director
- Sishtla Ramakrishnan - Director
The latest financial statements of Shreegen Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Shreegen Pharma is 29AASCS2680K1ZJ, registered in Karnataka. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Shreegen Pharma is U24233TG2012PLC083695. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shreegen Pharma has 16 court cases on record: 3 filed by the company and 13 filed against it. 8 are pending. Most are in the high courts.
Shreegen Pharma was incorporated on 18 October 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
Shreegen Pharma has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹13.15 Cr; the latest was in May 2022.
The peers of Shreegen Pharma by revenue are Horster Biotek Private Limited, Omkrown Pharam-Chem Private Limited, Proventus Life Sciences Private Limited, Thexa Pharma Private Limited, Xenocor Pharmalab Private Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sishtla Ramakrishnan was appointed as Director on 01 Aug 2025. Chandra Balireddy Kotthapalli was appointed as Additional Director on 14 May 2025. Rajeev Dinesh Srivastava was appointed as Additional Director on 14 May 2025. Shreegen Pharma has 11 board changes on record in total.
Yes, Shreegen Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-06-0002768).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages